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We report 10 patients (5 familial, 5 sporadic) with facioscapulohumeral 
muscular dystrophy (FSHD) with onset of facial and shoulder girdle 
weakness in early infancy. They showed the same broad range of clin­
ical signs and symptoms as can be seen normally in FSHD. In 7 patients 
Southern blotting with p13E-11 was performed which showed an ab­
normal EcoRI fragment (13-22 kb) in 6 of them. We conclude that early 
onset FSHD does not differ from regular FSHD clinically or genetically. 
However, the precise mechanisms Involved in the extensive clinical 
variability of the disease are still unknown. © 1995 John Wiley & Sons, Inc. 
Key words: facioscapulohum eral m uscular dystrophy • infancy- 
childhood • hearing loss • retinal vasculopathy * DNA rearrangement
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Facioscapulohumeral muscular dystrophy is an 
autosom al-dom inant disorder characterized by 
weakness and atrophy of facial and shoulder girdle 
muscles. The clinical course is slowly progressive in 
most cases with successive involvement of abdominal, 
foot extensor, upper arm, and pelvic girdle mus­
cles.24 Sporadic cases do occur, but can only be ac­
cepted as such if both parents have been examined,25 
High-frequency hearing loss has been recog­
nized to be part of the disease and to be present in 
more than 50% of the patients.5,26 The severity o f 
the hearing loss varies between subjects at any age, 
but tends to be progressive^ with gradual involve­
m ent of all frequencies.5 Retinal vascular abnor­
malities can be identified b^ fluorescein angiogra­
phy in many familial and sporadic cases.9. The 
initial denomination of Coats’ disease for this re t­
inal vasculopathy is incorrect as Coats’ disease is 
defined as an usually unilateral, nonhereditary, ex-
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udative vascular retinopathy,26 There appears to 
be no relationship between the severity of the mus­
cle weakness, and the severity of the hearing loss or 
the  re tina l vasculopathy . The pathogenetic  
mechanism of both hearing loss and retinal vascu­
lopathy in FSHD is still unknown.
In 1990, the FSHD gene was mapped to chro­
m osom e 4q35 by linkage analysis/4 Recently, 
p robe p l3 E - l l ,  which was isolated from a ho- 
meobox domain-containing cosmid and maps to 
4q35, has been shown to detect abnormal small 
fragm ents with the restriction enzyme EcoRl in pa­
tients o f autosomal-dominant families as well as in 
sporad ic  cases.35 T h ese  small fragm ents were 
shown to be caused by deletions of homeobox do­
m ain -con ta in ing  repeat units.8 However, some 
families with typical FSHD did not show link­
age.2,12 Also, families as well as sporadic cases have 
been  reported  that did not show abnormal frag­
ments with p l3 E - l l  suggesting genetic heteroge­
neity or mutations resulting in nondetectable rear-lqai a «2 a f;
rangem ents. ' '
In  most FSHD patients the first symptoms of
muscle weakness are noticed at the end of the first
or in the second decade.24,30 A severe form  of
FSHD in young children has been frequently re- 
p o r t e d . 21-23,27-29,32,36,37 g r0oke was
the first to describe infantile FSHD as a special 
form  of the disease and he even suggested a spe­
cific clinical course and m ode of inheritance in this 
presentation o f  FSHD.3 Indeed, many of the these 
infantile cases are sporadic, or in the hereditary 
cases only slight facial weakness can be observed in
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one o f the parents. Initially, his ideas of clinical 
and genetic heterogeneity were also supported by 
the fact that, in many of these infantile cases, high- 
frequency hearing loss and retinal vascular abnor­
malities were reported , and mental retardation in 
some of them.
As part of a large clinical and genetic study of 
FSHD in T he  Netherlands, we searched for pa­
tients with onset o f  facial and shoulder girdle 
weakness in early childhood. O ur purpose was to 
determine the clinical and genetic features of these 
early onset cases and to be able to answer the ques­
tion of w hether this form of FSHD really is a dis­
tinct entity or just part o f  the FSHD spectrum. In 
familial cases, at least one affected family member 
had electromyography and muscle biopsy findings 
compatible with FSHD. Sporadic cases were ac­
cepted as such only if both parents and siblings 
were exam ined physically; if this has not been 
done, it is explicitly stated in the text.
CASE REPORTS
We identified 10 patients with early onset FSHD. 
Six cases have been reported  earlier.6 Four addi­
tional cases are described below. T he clinical and 
genetic data of all 10 patients are summarized in
Tables 1 and 2.
Case 7. This mentally re tarded  20-year-old male 
could not close his eyes from  early infancy and  his 
mother noticed him to be floppy. At the age of 2 he 
could walk without support. Audiological exami­
nation was perform ed at age 3 because of delayed 
speech, but was reported  to be normal. He had 
never been able to whistle or to drink through a 
straw. At the age o f 9 he had corrective surgery for 
a hanging lower lip. In  the same period difficulties 
with his shoulder function were noticed, He visited
a school for mentally retarded and, upon exami­
nation, he had low-set malformed ears, a high- 
arched palate, divergent strabism with slight p ro ­
ptosis, and facial weakness with an inability to close 
his eyes fully (Fig. 1). Shoulder girdle weakness 
was present with severe limitation of abduction 
and anteflexion of both arms. T here was some at­
rophy of the sternocleidomastoid and pectoralis 
muscles. Flexion contractures of the proximal in- 
terphalangeal joints of the hands were noticed. A 
thoracal kyphoscoliosis was observed with in ­
creased lumbar lordosis, bu t no scapular winging. 
He had a waddling gait and weakness of the left 
foot extensors. H earing was not obviously im ­
paired: he could hear a whispering voice at a 4-m 
distance.
The patient is from a family with autosomal- 
dominant FSHD. His 49-year-old mother and his 
grandfather are affected; two younger brothers 
aged 18 and 15 years, respectively, do not have any 
signs or symptoms of muscle weakness. Southern 
blot analysis with p l3 E - l l  in this family revealed 
an abnormal 18-kb fragment in this boy and his 
affected mother.
Case 8. This 17-year-old boy reportedly always 
slept with his eyes open. Early motor development 
was normal but, at the age of 3 years, hyperactivity, 
clumsiness, and a speech delay were noticed. He 
appeared to be mildly mentally retarded at the age 
of 5 and went to a special school, Neurological ex­
amination at age 7 showed facial and shoulder gir­
dle weakness, scapular winging, increased lumbar 
lordosis, and a waddling gait. Serum CK level was 
683 U/L (normal <  100 U/L); electromyography 
showed no abnormalities and muscle biopsy find ­
ings were compatible with a myopathy. Audiome­
try revealed right-sided hearing loss of 60 db at
Table 1. Clinical data of 10 early onset cases of FSHD.
Case no./ Severity Serum CK Muscle Mental Hearing Retina
sex/age (yr) of disease* (U/L) EMG biopsy retardation loss abnormal
1 /F/30 Moderate ------------ --------- - — — — —
2/M/5 Moderate ------------ ------------ ----------- ± —
3/M/8 Mild ------------ ----------- — ------------
4/M/30 Severe 1265 Myopathic Myopathy — ------------ ------------
5/F/18 Severe ------------ ------------ ----------- — + i |m
6/M/12 Moderate 426 Myopathic ---------- — -------—
7/M/20 Moderate ------------ ------------ ----------- + ------------ ------------
8/M/17 Severe 683 Normal Myopathy + + ------------
9/M/11 Moderate 587 Normal Dystrophy + + + (Coats)
10/M/13 Moderate ------------ Myopathic ----------- —
FSHD: facioscapulohumeral muscuiar dystrophy; CK: creatine kinase, normal value <100 U/L; EMG: electromyography. 
* Classification of severity of disease as ,,miid,,, 11 moderate," or ‘'severe" according to Lunt et al.20 
Cases 1-6 have been described earlier.6
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Table 2. Genetic data of 10 early onset cases of FSHD
Case no/sex/age
(yr)
Familial/
sporadic
Parent
affected
Severity of disease* 
in affected parent
Size of EcoRI fragment
(kb)
1 /F/30 Familial Father Mild 22
2/M/5 Familial Father Mild 15
3/M/8 Familial Father Moderate 16.5
4/M/30 Familial Father Moderate
5/F/18 Sporadic ---------- — 13
6/M/12 Sporadic --------- ---------- No small fragment
7/M/20 Familial Mother Moderate 18
8/M/17 Sporadic ---------- ---------- 13.5
9/M/11 Sporadic ---------- - —
10/M/13 Sporadic ----------
FSHD: facioscapulohumeral muscular dystrophy. 
*See Table 1.
4000 Hz. Since then the disease clearly progressed: 
at age 12, walking stairs and standing up from a 
chair had become very difficult. Examination at 
this time showed a bilateral foot drop in addition to 
the other described features.
His parents and elder sister were healthy and 
had no signs or symptoms of muscle weakness. 
Southern blot analysis with p l3 E - l l  showed a new 
ifctfRI fragment of 13.5 kb in the boy, which was 
not found in any of the other family members.
Case 9. This mentally retarded 11-year-old boy 
had a slow motor development; he walked without 
support at the age of 2 1/2 years. It was noticed that 
he always kept his mouth open. At the age of 1 
year, retinal exudative teleangiectasis with left ret­
inal detachm ent led to a diagnosis of bilateral 
Coats’ disease. Cryotherapy was performed on sev­
eral occasions, In the first years recurrent middle 
ear infections were initially blamed for impaired 
hearing function. Audiom etry at the age o f  3 years 
showed bilateral high-frequency hearing loss of 65 
dB, and hearing aids were prescribed. Examina­
tion at age 11 showed a re tarded  boy with an 
opened  m outh and immobile face due to facial 
weakness and  atrophy, scapular winging, shoulder 
girdle weakness and atrophy, and increased lum ­
b ar lordosis with p ro tru d in g  of the abdom en. 
Gower’s sign was positive. His IQ was in the 60-80 
range. Serum creatine kinase was 587 U/l (normal 
< 1 0 0  U/L). Electromyography, computer tomog­
raphy of several muscle groups, and magnetic res­
onance brain imaging all gave normal results. Mus­
cle biopsy findings were compatible with muscular 
dystrophy.
Case 9 is the only child. There is no family his-
. v-
FIGURE 1. Case 7. A 20-year-old mentally retarded male with early onset facioscapulohumeral muscular dystrophy. His mother 
is also affected.
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tory of muscle weakness, but the parents have not 
been exam ined physically. DNA analysis is not 
available at present.
Case 10. This 13-year-old boy slept with his eyes 
open from early infancy and he had never been 
able to whistle. At the age of 6 he had a blow on his 
left eye. After this accident facial asymmetry with 
drooping of the left corner o f the mouth and dys­
arthria were noticed by his parents and speech 
therapy was started. From the age of 12 years, p ro­
gressive muscle weakness of the left shoulder was 
observed causing increasing difficulties with gym­
nastics at school. His intelligence is above average. 
On examination he had severe symmetrical facial 
weakness, and weakness and atrophy of the shoul­
der girdle and upper arm  muscles with scapular 
winging. T h e  delto id  muscles were relatively 
spared. He had a flattened lumbar lordosis and a 
waddling gait, bu t otherwise no weakness or atro­
phy of the lower extremities was found. Hearing 
function seemed to be normal, but audiometry was 
not perform ed. Electromyographic findings were 
compatible with a myopathy.
T here  was no family history o f a neurom uscu­
lar disorder. Both parents are healthy and showed 
no abnormalities at examination. Two other sib­
lings were reported  to have no signs or symptoms 
of muscle weakness, bu t they were not physically 
examined. DNA analysis has not yet been per­
formed.
DISCUSSION
Several clinical observations led researchers to for­
mulate the question of w hether FSHD might be a 
genetically heterogeneous disorder. One of the 
most peculiar observations is that of infantile or 
early onset FSHD, which is characterized by pro­
gressive muscle weakness leading to severe disabil­
ity at young age, and is frequently associated with 
high-frequency hearing  loss and retinal vascu­
lopathy rang ing  from  severe Coats’ disease to 
mild tortuositas of retinal vessels. At least 55 early 
onset cases have been  published in the litera­
tu re .1,7,1011,14^ 19^ 1”23,27-29,32,36,37 It appears, how­
ever, that these cases are not a real representation 
of FSHD in early childhood and most o f them are 
severely affected cases by both ascertainment and 
publication bias. O torhinolaryngologists tend  to 
repo rt on patients with severe hearing loss,16,22 
ophthalm ologists  on  pa tien ts  with C oats’ dis­
ease,14,27 and neurologists on patients with severe 
muscle weakness.1,7,15. Sporadic early onset cases 
seem to be m ore severely affected than familial
ones, but this is probably due to ascertainment bias 
as less affected sporadic cases often go undiag­
nosed. This bears relevance to the question of 
whether this early onset FSHD really is a clinically 
and/or genetically distinct disorder or just the end 
of the clinical spectrum of FSHD.
We report 10 patients with onset of facial and 
shoulder girdle weakness in early childhood. Six of 
them were identified by a careful search in a large 
patient material in T he N etherlands and have 
been described earlier.6 O f these 10 cases, 5 were 
familial and 5 sporadic. Clinical course and rate of 
progression were not clearly different between the 
two groups. High-frequency hearing loss and re t­
inal vasculopathy were only found in sporadic 
cases: hearing loss in 4, and retinal vasculopathy in
2. However, audiometry has not been performed 
in all, and retinal fluorescein angiography, which is 
necessary to identify subtle abnormalities of the 
retinal vessels, was done in only 3. So, clinically, 
our early onset cases represent the full spectrum of 
FSHD, including the presence of hearing loss and 
retinal vasculopathy in some of them.
Only part of the problem was resolved by the 
recent finding that hearing loss and retinal vascu­
lopathy are part of FSHD. It is still unknown which 
mechanisms are responsible for the broad clinical 
spectrum of FSHD, and one might speculate about 
genetic mechanisms that might be involved. It has 
been recently shown that FSHD is associated with 
DNA rearrangements detected by the probe p l3E -
1 1  35 proke detects a polymorphic chromo­
some 4-specific EcoRl fragment, which is usually 
larger than 28 kb in norm al individuals, b u t  
shorter (14-28 kb) in FSHD patients. These re a r­
rangements are due to deletions of integral copies 
of a 3.2-kb tandemly repeated unit.8 Trinucleotide 
repeats are known to be involved in other dom i­
nant disorders such as fragile X syndrome, m yo­
tonic dystrophy, and H un ting ton’s disease. I n ­
creasing am plification o f these tr inuc leo tide  
repeats in the mutant gene in following genera­
tions cause these diseases to become clinically m an ­
ifest at an earlier age in succeeding generations, a 
mechanism called anticipation. Deletion, instead of 
amplification, of the 3.2-kb repeats in FSHD pa­
tients may well play a role in its pathogenesis, b u t it 
is unlikely that anticipation is present in FSHD be­
cause within families with autosom al-dom inant 
FSHD the abnormal DNA fragment allways has 
the same size despite large variability in phenotypic 
expression. Earlier reports concluded that there is 
no correlation between the size of the EcoRl f rag ­
ment and disease severity in sporadic cases.13
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FIGURE 2. Case 6. A 12-year-old boy with early onset FSHD with severe facial and shoulder girdle weakness. His parents have 
no signs of muscle weakness.
A genetic mechanism, which may mimic antic­
ipation if the parents are clinically not affected, is 
germ-line mosaicism. Identical small EcoRl frag­
ments have been found in affected siblings, bu t not 
in their healthy parents, which is very suggestive o f 
germ-line mosaicism.13,33 Recently, a male patient 
was identified with a nonaffected father showing a 
weak small fragment of the same size as in his 
daughter, suggesting somatic mosaicism (Bakker 
and Wijmenga, personal communication).
We found small £coRI fragments ranging from  
13 to 22 kb in 6 of 7 early onset cases (Table 2), 
Case 6 did not show an abnormal fragment: the 
patient had all the clinical hallmarks of FSHD (Fig. 
2) and high-frequency hearing loss. His parents 
and two siblings were normal at examination. In  
our group of early onset cases there was a tendency 
of fragments to be shorter in more severely af­
fected cases. T he  question remains why some fam ­
ilies and sporadic cases do not show an abnormal 
fragment. Hypothetically, this might be due to a 
point mutation or a very large deletion, but genetic 
heterogeneity cannot be excluded.
Genomic imprinting, the asymmetrical impact 
of one parental chromosome of an autosomal pair, 
seems not to play a role in early onset FSHD. From  
the case reports in the literature, as well as from  
our own material, one may conclude that there is 
no relationship between the occurrence and sever­
ity of the disease, and the sex of the affected par­
ent. Still, there is the possibility of a modifying 
gene, even in the unaffected parent, as proposed 
by Brooke.4
We conclude from this study that neither clin­
ically n o r  genetically early onset FSHD differs 
from  adult onset FSHD. T h e  mechanisms respon­
sible for the broad clinical spectrum of FSHD still 
have to be identified and definite answers can only 
be given after the FSHD gene has been found. In 
the m ean time it would be worthwhile to investi­
gate all reported  patients with early onset FSHD, 
especially sporadic cases with mental retardation, 
hearing loss, and retinal vasculopathy, and their 
family members with probe p 13E-11 for the pres­
ence of abnormal EcoRl fragments.
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